Programmed cell death ligand 1
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract INTRODUCTION Immune Checkpoint Inhibitors (ICIs) have become a revolutionary milestone in the immune-oncology field and…
Previous studies suggest that radiotherapy (RT) can induce immune activation, which not only reduces the progression of tumors…
Immunotherapy and its mechanisms are being studied in a wide variety of cancers. Programmed cell death ligand 1 (PDL1) is…
Programmed cell death ligand 1 (PD-L1) expressed in cancer cells interacting with its receptor programmed cell death 1 (PD-1…
Click here to listen to the Podcast
Background Lung adenocarcinoma (AD) is a common variant of non-small cell lung cancer (NSCLC). Programmed cell death protein 1…
Head and neck cancer (HNC) is a common malignant tumor, but traditional therapeutic methods have unsatisfactory curative effects…
Programmed cell death 1 (PD-1)/PD-1 ligand 1 (PD-L1) pathway blockade has emerged as a promising strategy for cancer therapy…
Previous pre-clinical modeling demonstrated that phosphatidylserine (PS) targeting antibodies are capable of significantly…